ANIPNasdaqPharmaceutical PreparationsFiscal year ends December 31

ANI PHARMACEUTICALS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$72.56+0.27 (+0.37%)

Close on Oct 19, 2026

Market cap: $1.59B
P/E (TTM): 15.4
Dividend yield: –

ANI PHARMACEUTICALS INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q2 2026 2026-06-30	TTM Q1 2026 2026-03-31	TTM FY 2025 2025-12-31	TTM Q3 2025 2025-09-30	TTM Q2 2025 2025-06-30	TTM Q1 2025 2025-03-31	TTM FY 2024 2024-12-31	TTM Q3 2024 2024-09-30	TTM Q2 2024 2024-06-30	TTM Q1 2024 2024-03-31	TTM FY 2023 2023-12-31	TTM Q3 2023 2023-09-30	TTM Q2 2023 2023-06-30	TTM Q1 2023 2023-03-31	TTM FY 2022 2022-12-31	TTM Q3 2022 2022-09-30	TTM Q2 2022 2022-06-30	TTM Q1 2022 2022-03-31	TTM FY 2021 2021-12-31	TTM Q3 2021 2021-09-30	TTM Q2 2021 2021-06-30	TTM Q1 2021 2021-03-31	TTM FY 2020 2020-12-31	TTM Q3 2020 2020-09-30	TTM Q2 2020 2020-06-30	TTM Q1 2020 2020-03-31	TTM FY 2019 2019-12-31	TTM Q3 2019 2019-09-30	TTM Q2 2019 2019-06-30	TTM Q1 2019 2019-03-31	TTM FY 2018 2018-12-31	TTM Q3 2018 2018-09-30	TTM Q2 2018 2018-06-30	TTM Q1 2018 2018-03-31	TTM FY 2017 2017-12-31	TTM Q3 2017 2017-09-30	TTM Q2 2017 2017-06-30	TTM Q1 2017 2017-03-31	TTM FY 2016 2016-12-31	TTM Q3 2016 2016-09-30
Revenue	978	924	883	827	747	674	614	555	539	517	487	449	401	359	316	283	251	226	216	212	213	213	208	199	198	203	207	216	215	208	202	192	189	187	177	168	158	145	129	108
Cost of Revenue	387	362	341	321	291	274	250	223	208	193	182	164	149	142	139	136	128	115	101	91	87	85	87	80	75	70	63	65	66	67	73	73	79	83	79	75	71	62	49	35
Gross Profit	591	562	542	506	456	400	364	332	331	324	305	285	252	216	178	147	123	111	116	121	126	128	121	119	122	133	143	150	149	141	129	118	110	103	98	92	87	83	80	73
Research & Development	50	52	52	56	54	45	45	38	39	39	34	30	26	23	22	20	15	14	11	12	12	13	16	17	19	22	20	19	18	18	15	15	13	9.55	9.07	6.55	4.96	3.56	2.91	3.43
Selling, General & Admin	325	315	318	305	307	278	250	224	187	173	162	150	138	132	124	122	109	96	84	68	66	69	65	65	63	56	56	55	53	48	44	40	36	33	32	30	29	29	28	26
Total Costs & Expenses	828	800	772	755	732	668	614	544	489	460	440	407	382	365	352	344	311	288	256	228	223	218	224	220	214	199	190	183	180	175	166	160	159	156	149	146	137	126	109	83
Operating Income	150	124	111	72	15	6.47	0.58	12	50	57	47	42	19	-6.19	-35	-61	-59	-62	-40	-16	-9.38	-5.13	-16	-21	-16	4.11	16	32	35	33	35	31	31	30	28	22	21	19	20	25
Interest Expense	31	32	33	33	32	33	34	36	38	37	36	32	31	30	29	25	20	16	12	10	10	9.88	9.48	9.96	11	12	13	14	14	15	15	14	13	12	11	11	11	11	11	11
Other Non-Operating Income	-1.12	1.09	1.93	-0.29	-1.98	-3.80	-4.03	-2.69	-0.19	-0.16	-0.16	-0.17	-0.09	0.73	0.67	-1.98	-3.09	-3.92	-4.34	-1.81	-0.97	-1.02	-0.49	-0.45	-0.25	-0.09	-0.23	-0.60	-0.54	-0.62	-0.55	-0.07	0.00	0.01	0.06	0.02	-0.10	-0.09	-0.07	-0.03
Asset Impairment Charges	–	–	0.77	–	–	–	7.60	–	–	–	0	0	0	0	0.57	2.37	2.37	2.37	2.37	0.34	0.34	0.34	0.45	0.08	0.08	0.08	0.08	0	0	0	0	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	-0.38	-0.30	0	0	5.35	5.35	5.35	5.35	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Legal Settlements	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	-8.75	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Pretax Income	143	116	96	51	-15	-28	-22	-7.50	36	43	20	13	-11	-35	-63	-88	-83	-82	-56	-28	-20	-16	-26	-31	-27	-7.63	3.16	18	21	18	20	17	17	18	16	10	9.07	7.47	8.68	14
Income Tax Expense	34	24	17	9.98	-4.54	-6.51	-3.69	-0.41	8.49	7.50	1.09	-0.18	-5.38	-8.28	-15	-20	-19	-19	-13	-5.49	-3.17	-0.57	-3.41	-7.48	-7.05	-6.26	-2.94	1.79	3.06	4.43	4.56	-11	-14	-16	17	-2.92	-3.77	-3.73	4.74	-4.64
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-20	-1.37	6.09	16	18	14	15	0.44	0.12	0.02	-1.08	7.47	5.30	3.74	3.93	7.89
Net Income incl. Noncontrolling Interests	108	92	78	41	-10	-21	-19	-7.09	27	36	19	13	-5.16	-26	-48	-68	–	–	-43	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income	108	92	78	41	-10	-21	-19	-7.09	27	36	19	13	-5.16	-26	-48	-68	-64	-63	-43	-22	-17	-15	-23	-24	-20	-1.37	6.09	16	18	14	15	0.44	0.12	0.02	-1.08	7.47	5.30	3.74	3.93	7.89
Preferred Dividends	0.34	0.75	1.16	1.56	1.63	1.63	1.63	1.63	1.63	1.63	1.63	1.63	1.63	1.63	1.63	1.41	1.00	0.60	0.19	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Net Income to Common	106	91	77	38	-13	-23	-20	-8.72	25	34	17	12	-6.79	-28	-50	-69	-65	-63	-43	-22	-17	-15	-23	-24	-20	-1.36	6.09	16	17	14	15	0.41	0.11	0.02	-1.08	7.42	5.26	3.72	3.91	7.86
EPS (Basic)(per share)	4.92	4.20	3.50	1.71	-0.75	-1.26	-1.04	-0.53	1.20	1.64	0.86	0.54	-0.47	-1.71	-3.05	-4.47	-4.29	-4.52	-3.40	-1.83	-1.42	-1.28	-1.88	-1.99	-1.71	-0.13	0.51	1.37	1.48	1.17	1.31	0.03	0.01	0.00	-0.09	0.65	0.46	0.33	0.34	0.69
EPS (Diluted)(per share)	4.70	4.01	3.32	1.63	-0.77	-1.27	-1.04	-0.55	1.17	1.60	0.85	0.52	-0.48	-1.71	-3.05	-4.47	-4.29	-4.52	-3.40	-1.83	-1.42	-1.28	-1.88	-1.99	-1.71	-0.15	0.50	1.35	1.45	1.15	1.30	0.01	-0.01	-0.01	-0.09	0.64	0.46	0.33	0.34	0.69
Shares Outstanding (Basic, Weighted)(shares)	21	20	20	20	20	19	19	19	19	19	18	17	17	16	16	16	15	14	13	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	11	11	11
Shares Outstanding (Diluted, Weighted)(shares)	22	21	21	20	20	20	19	19	19	19	18	17	17	16	16	16	15	14	13	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12	12
EBITDA	236	213	203	163	100	82	68	72	110	117	107	101	77	51	22	-4.65	-6.04	-11	7.46	29	35	39	29	22	25	44	61	76	78	75	69	63	61	60	56	49	46	43	42	44
Total Interest Income	15	14	13	12	13	14	16	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 60.4%
Operating margin: 15.4%
Net margin: 11.1%
Return on equity, FY2025: 16.6%

Financial strength

Current ratio: 2.91
Debt to equity: 0.50
Debt to assets: 20.2%
Cash to current liabilities: 127.0%

Valuation

P/E ratio: 15.4
Price to sales: 1.63
Price to book: 2.66
Dividend yield: –